How Janssen is Collaborating with Patients and Sites to Advance DCTs

As the Director of patient insights for Janssen, Alyson Gregg is focused on leading Janssen to incorporate direct patient insights on clinical trial protocol and work with compound development teams to modify trials as appropriate, to improve the patient experience and clinical trial success. Ms Gregg has over 20 years of experience at Johnson & Johnson.

Morgan Wooten is the Investigator and Patient Engagement Program Team Leader for the Oncology TA at Janssen (the pharmaceutical company of Johnson & Johnson). In this role, she is responsible for TA-level strategies while overseeing the development and deployment of the recruitment, retention and engagement plans in support of the oncology portfolio. Ms Wooten has been with J&J since 2017 and has held various positions of increasing responsibility within the Patient and Portfolio Solutions team.